Listed
Accretion Pharmaceuticals Limited IPO
Accretion Pharmaceuticals Limited is preparing to launch its Initial Public Offering (IPO) to raise funds for expanding its pharmaceutical business. The company primarily focuses on manufacturing and marketing a wide range of pharmaceutical products, including tablets, capsules, ointments, and liquid formulations. It caters to both the domestic and international markets, offering contract manufacturing services to over 200 clients.
Min Investment
₹1,21,200
Lot Size
1200 Shares
Price Range
₹96.0 - 101.0
Issue Size (₹ Cr.)
₹29.75 Cr
IPO Type
NSE SME
Key Metrics
Face Value
₹ 10
GMP
₹ 0
Subscription
7.67x
EPS
₹ 2.82
P/E Ratio
35.82 x
RoNW
72.47%
ROE
25.20%
Debt to Equity (₹ Cr.)
2.60
Timeline
IPO Opened13/05/2025Tuesday
IPO Closed16/05/2025Friday
Allotted19/05/2025Monday
Refunded20/05/2025Tuesday
Listed21/05/2025Wednesday
Strengths
- Experienced management team with over a decade in pharma operations and strategy.
- WHO-GMP certified facility ensuring high-quality manufacturing standards.
- Wide product portfolio covering multiple dosage forms and therapeutic segments.
- Established B2B network with over 200 domestic and international clients.
- Strong financials with consistent revenue and profit growth.
Weaknesses
- Modest scale of operations limits its competitive edge and market reach.
- Working capital intensive model strains liquidity and cash flow.
- Limited export revenue with only 14% of sales from international markets.
- High debt-to-equity ratio increases financial risk and dependency on borrowed funds.
- Regulatory risks related to compliance with stringent pharmaceutical regulations.
Accretion Pharmaceuticals Limited IPO - GMP Trend
| GMP Date | Ipo Price | GMP | Estimate Listing Price | |
|---|---|---|---|---|
| 20/05/2025 | ₹ 101.00 | ₹ 0 | ₹ 101 | |
| 19/05/2025 | ₹ 101.00 | ₹ 0 | ₹ 101 | Allotment |
| 18/05/2025 | ₹ 101.00 | ₹ 0 | ₹ 101 | |
| 17/05/2025 | ₹ 101.00 | ₹ 0 | ₹ 101 | |
| 16/05/2025 | ₹ 101.00 | ₹ 0 | ₹ 100-105 | IPO Closed |
| 15/05/2025 | ₹ 101.00 | ₹ 8 | ₹ 105-115 | |
| 14/05/2025 | ₹ 101.00 | ₹ 16 | ₹ 115-120 | |
| 13/05/2025 | ₹ 101.00 | ₹ 8 | ₹ 100-110 | Live |
| 12/05/2025 | ₹ 101.00 | ₹ 0 | ₹ 0 (0.0%) | |
| 11/05/2025 | ₹ 101.00 | ₹ 0 | ₹ 0 (0.0%) | |
| 10/05/2025 | ₹ 101.00 | ₹ 0 | ₹ 0 (0.0%) | |
| 09/05/2025 | ₹ 101.00 | ₹ 0 | ₹ 0 (0.0%) | |
| 08/05/2025 | ₹ 101.00 | ₹ 0 | ₹ 0 (0.0%) | |
| 07/05/2025 | ₹ 101.00 | ₹ 0 | ₹ 0 (0.0%) |
Financials
| Period Ended | 30-09-024 | 31-03-2024 | 31-03-2023 | 31-03-2022 |
|---|---|---|---|---|
| Assets (In Cr) | 29.34 | 27.05 | 20.58 | 17.74 |
| Revenue (In Cr) | 11.89 | 33.94 | 29.53 | 22.58 |
| Profit After Tax (In Cr) | 1.57 | 3.88 | 0.1 | 0.08 |
| Net Worth (In Cr) | 9.91 | 5.35 | 3.84 | 3.08 |
| Reserves and Surplus (In Cr) | 1.74 | 1.35 |
Subscription Details
IPO Bidding Live Updates from NSE SME
| Day | # of Share Offered | Number of Lots Offered | 14-05-2024 | 15-05-2024 | 16-05-2024 |
|---|---|---|---|---|---|
| QIB | 1,41,600 | 118 | 0.00x | 0.75x | 12.14x |
| NII | 12,22,800 | 1019 | 0.51x | 0.92x | 4.28x |
| RII | 12,22,800 | 1019 | 1.86x | 4.01x | 10.54x |
| Total | 25,87,200 | 2156 | 1.12x | 2.37x | 7.67x |
IPO Bidding Live Number of Shares by Category
| Category | Number of Shares offered | Number of Shares Bid | Bid Amount(Rs Cr) | ||
|---|---|---|---|---|---|
| QIB | 1,41,600 | 17,19,600 | 17.37 | ||
| NII | 12,22,800 | 52,36,800 | 52.89 | ||
| RII | 12,22,800 | 1,28,85,600 | 130.14 | ||
| Total | 25,87,200 | 1,98,42,000 | 200.40 |
Company Details
- 29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvad Sanand,
+91-97148 82929
- compliance@accretionpharma.com
- https://accretionpharma.com/
Registrar Details
- N/A
04067162222, 04079611000
- apl.ipo@kfintech.com
- https://kosmic.kfintech.com/ipostatus/
